- Filed
- Nov 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 10, 2025 | 21.22M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 18.27M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 15.95M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 12.82M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 12.77M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $476K |
| Capex | Q3 2025 · Sep 30, 2024 | $420K |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$117.77M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$115.15M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $123.58M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $105.6M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2024 | $100.3M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $329.12M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $298.92M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $382.82M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $530.7M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $566.5M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $654.95M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $31.88M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $53.79M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $78.84M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $108.04M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $328.2M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $379.59M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $407.97M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $490.86M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$2.13 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$8.38 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$3.48 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$11.83 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$2.13 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$8.38 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$3.48 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$11.83 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $10.69M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $34.52M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $11.77M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $37.52M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $28.17M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $106.48M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $39.5M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $122.94M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$38.85M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$133.73M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$44.58M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$151.06M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$37.25M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$141.76M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$50.51M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$157.61M |
| Revenue | Q3 2025 · Sep 30, 2025 | $15K |
| Revenue | Q3 2025 · Sep 30, 2025 | $30K |
| Revenue | Q3 2025 · Sep 30, 2024 | $34K |
| Revenue | Q3 2025 · Sep 30, 2024 | $50K |